In recent years it has been supposed that impaired intestinal permeability represents an early event preceding the onset of inflammatory bowel disease (IBD). Since zonulin has been proposed as a biomarker of intestinal permeability, we investigated its role in patients with IBD and the correlation between serum and fecal zonulin.
Serum zonulin in patients with inflammatory bowel disease: a pilot study
Caviglia, Gian Paolo;DUGHERA, FRANCESCA;Ribaldone, Davide G;Rosso, Chiara;Abate, Maria L;Pellicano, Rinaldo;Smedile, Antonina;Saracco, Giorgio M;
2019-01-01
Abstract
In recent years it has been supposed that impaired intestinal permeability represents an early event preceding the onset of inflammatory bowel disease (IBD). Since zonulin has been proposed as a biomarker of intestinal permeability, we investigated its role in patients with IBD and the correlation between serum and fecal zonulin.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Minerva Med-5787_Manoscritto_V1_2018-07-16.pdf
Accesso aperto
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
202.26 kB
Formato
Adobe PDF
|
202.26 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
